iSERA Lifesciences Ltd

From a low of Rs 5.36 to a remarkable Rs 151.05, iSERA Lifesciences Ltd has surged over 2,600% in the past year, culminating in a fresh 52-week high on 17 Jun 2026. This extraordinary price momentum stands out sharply against the broader market backdrop, where the Sensex has declined by 10.12% over the same period.

iSERA Lifesciences Ltd has witnessed a dramatic shift in its valuation parameters, moving from a non-qualifying valuation status to being classified as very expensive. Despite this, the stock has delivered extraordinary returns year-to-date and over the past year, significantly outperforming the Sensex. This article analyses the recent valuation changes, compares them with peer averages, and assesses the implications for investors.

iSERA Lifesciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 September 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 16 September 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

iSERA Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

iSERA Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Covidh Technologies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Covidh Technologies Ltd, a micro-cap stock, has experienced a notable shift in its financial trend, moving from positive growth to a flat trajectory in the latest quarter ending June 2026. Despite a modest increase in profit after tax (PAT) over the last six months, the company’s earnings before depreciation, interest and taxes (PBDIT) and profit before tax excluding other income (PBT less OI) have deteriorated to their lowest quarterly levels, signalling challenges ahead for investors.

Covidh Technologies Ltd is rated Sell by MarketsMOJO. This rating was last updated on 03 Jul 2025, but the analysis below reflects the stock’s current position as of 30 July 2026, incorporating the latest fundamentals, returns, and financial metrics available today.

Covidh Technologies Ltd is rated 'Sell' by MarketsMOJO, a rating that was established on 03 Jul 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 19 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Covidh Technologies Ltd has reached a significant milestone by touching a new 52-week high of Rs.143.9 on 8 July 2026, marking a continuation of its strong upward momentum over the past three weeks.

Covidh Technologies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Surging past Rs 142.45 on 7 Jul 2026, Covidh Technologies Ltd has marked a significant milestone by reaching a fresh 52-week high, propelled by a sustained 21-day winning streak and a remarkable 51.27% return over this period.

Surging to a new 52-week high of Rs 139.7 on 6 Jul 2026, Covidh Technologies Ltd has demonstrated remarkable price momentum, climbing steadily for 21 consecutive sessions and delivering a 55.76% return over this period. This rally stands out amid a broadly rising Sensex, which itself has gained 3.54% over the past three weeks.

With a remarkable 60.38% gain over the past 21 trading sessions, Covidh Technologies Ltd surged to a fresh 52-week high of Rs 137 on 3 July 2026, showcasing a powerful momentum that has captivated market attention.

With a remarkable 65.13% gain over the past 21 trading days, Covidh Technologies Ltd surged to a fresh 52-week high of Rs 134.35 on 2 Jul 2026, showcasing a powerful momentum that has captivated market attention.

With a remarkable 70.02% gain over the past 21 trading sessions, Covidh Technologies Ltd surged to a fresh 52-week high of Rs 131.75 on 1 Jul 2026, outpacing its sector by 1.27% and demonstrating sustained momentum across multiple technical indicators.

With a sustained rally over the past 20 trading sessions, Covidh Technologies Ltd has surged to a fresh 52-week high of Rs 129.17 on 30 Jun 2026, marking a remarkable 66.69% gain during this period. This milestone reflects a powerful alignment of technical indicators and price momentum that has propelled the stock well above its previous levels.

Surging past its previous peaks, Covidh Technologies Ltd touched a fresh 52-week high of Rs 126.65 on 29 Jun 2026, marking a remarkable rally that has seen the stock gain over 63% in the last 19 trading sessions. This milestone reflects a powerful momentum build-up underpinned by a confluence of bullish technical indicators and sustained price strength.

Covidh Technologies Ltd is rated 'Sell' by MarketsMOJO, with this rating having been established on 03 July 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 27 June 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.